Brief: VYNE Therapeutics Q3 Revenue USD 169 Thousand
Nov 06 (Reuters) - VYNE Therapeutics Q3 net income USD -7.28 million. Q3 EPS from cont ops USD -0.17
Nov 06 (Reuters) - VYNE Therapeutics Q3 net income USD -7.28 million. Q3 EPS from cont ops USD -0.17